Acquired BCR-ABL1 fusion and IDH1 clonal evolution following BCL2 inhibitor treatment in refractory acute myeloid leukemia

被引:0
作者
Adrianzen-Herrera, Diego [1 ]
Jordan-Bruno, Ximena [1 ]
Devitt, Katherine A. [2 ]
Conant, Joanna L. [2 ]
Gardner, Juli-Anne [2 ]
机构
[1] Univ Vermont, Div Hematol & Oncol, Larner Coll Med, 89 Beaumont Ave,Given Bldg,E-214, Burlington, VT 05405 USA
[2] Univ Vermont, Dept Pathol & Lab Med, Larner Coll Med, Burlington, VT USA
关键词
PHILADELPHIA-CHROMOSOME; TRANSLOCATION; AML;
D O I
10.1016/j.leukres.2020.106494
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 20 条
[1]   Emergence of BCR-ABL1 Fusion in AML Post-FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance - A Case Series [J].
Alotaibi, Ahmad S. ;
Yilmaz, Musa ;
Loghavi, Sanam ;
DiNardo, Courtney ;
Borthakur, Gautam ;
Kadia, Tapan M. ;
Thakral, Beenu ;
Pemmaraju, Naveen ;
Issa, Ghayas C. ;
Konopleva, Marina ;
Short, Nicholas J. ;
Patel, Keyur ;
Tang, Guilin ;
Ravandi, Farhad ;
Daver, Naval .
FRONTIERS IN ONCOLOGY, 2020, 10
[2]   Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations [J].
Bacher, Ulrike ;
Haferlach, Torsten ;
Alpermann, Tamara ;
Zenger, Melanie ;
Hochhaus, Andreas ;
Beelen, Dietrich W. ;
Uppenkamp, Michael ;
Rummel, Mathias ;
Kern, Wolfgang ;
Schnittger, Susanne ;
Haferlach, Claudia .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (06) :713-720
[3]   Co-occurrence of chronic myeloid leukemia with chronic lymphocytic leukemia: a report of two cases [J].
Boddu, Prajwal ;
Gibbons, Jamie ;
Burger, Jan ;
Sivina, Mariela ;
Thakral, Beenu ;
Kanagal-Shamanna, Rashmi ;
Ferrajoli, Alessandra .
LEUKEMIA & LYMPHOMA, 2019, 60 (06) :1568-1571
[4]   Secondary Philadelphia chromosome in a patient with acute lymphoblastic leukemia [J].
Chen, L ;
Stamatoullas, A ;
Bastard, C ;
Tilly, H .
CANCER GENETICS AND CYTOGENETICS, 2004, 152 (02) :132-135
[5]   Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm [J].
Chen, Z. ;
Wang, W. ;
Verstovsek, S. ;
Cortes, J. E. ;
Medeiros, L. J. ;
Hu, S. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (06) :E150-E152
[6]   Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML [J].
DiNardo, C. D. ;
Tiong, I. S. ;
Quaglieri, A. ;
MacRaild, S. ;
Loghavi, S. ;
Brown, F. C. ;
Thijssen, R. ;
Pomilio, G. ;
Ivey, A. ;
Salmon, J. M. ;
Glytsou, C. ;
Fleming, S. A. ;
Zhang, Q. ;
Ma, H. ;
Patel, K. P. ;
Kornblau, S. M. ;
Xu, Z. ;
Chua, C. C. ;
Chen, Xufeng ;
Blombery, P. ;
Flensburg, C. ;
Cummings, N. ;
Aifantis, I. ;
Kantarjian, H. ;
Huang, D. C. S. ;
Roberts, A. W. ;
Majewski, I. J. ;
Konopleva, M. ;
Wei, A. H. .
BLOOD, 2020, 135 (11) :791-803
[7]   Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML [J].
DiNardo, C. D. ;
Stein, E. M. ;
de Botton, S. ;
Roboz, G. J. ;
Altman, J. K. ;
Mims, A. S. ;
Swords, R. ;
Collins, R. H. ;
Mannis, G. N. ;
Pollyea, D. A. ;
Donnellan, W. ;
Fathi, A. T. ;
Pigneux, A. ;
Erba, H. P. ;
Prince, G. T. ;
Stein, A. S. ;
Uy, G. L. ;
Foran, J. M. ;
Traer, E. ;
Stuart, R. K. ;
Arellano, M. L. ;
Slack, J. L. ;
Sekeres, M. A. ;
Willekens, C. ;
Choe, S. ;
Wang, H. ;
Zhang, V. ;
Yen, K. E. ;
Kapsalis, S. M. ;
Yang, H. ;
Dai, D. ;
Fan, B. ;
Goldwasser, M. ;
Liu, H. ;
Agresta, S. ;
Wu, B. ;
Attar, E. C. ;
Tallman, M. S. ;
Stone, R. M. ;
Kantarjian, H. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25) :2386-2398
[8]   Mutations in AML: prognostic and therapeutic implications [J].
DiNardo, Courtney D. ;
Cortes, Jorge E. .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, :348-355
[9]  
Kasi Pashtoon M, 2016, Leuk Res Rep, V5, P7, DOI 10.1016/j.lrr.2016.01.002
[10]   Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature [J].
Keung, YK ;
Beaty, M ;
Powell, BL ;
Molnar, I ;
Buss, D ;
Pettenati, M .
LEUKEMIA RESEARCH, 2004, 28 (06) :579-586